Broad-ranging therapeutic expertise

Hepatology

PHARMExcel has had the opportunity to work with some of the top, global key opinion leaders over the last 10 years to deliver Phase I-IV drug and early phase medical device studies in this field. Our experience, coupled with our strong, investigator relationships, suitably places us to ensure your trial(s) are successfully delivered. Our global regulatory experts can add input, strategy, and efficiencies, based on their in-depth understanding of the local and global regulatory landscape.

We have a key focus in Alcoholic Liver Disease (ALD), Acute on Chronic Liver disease (ACLF) and non-alcoholic steatohepatitis (NASH).

Gastroenterology / Inflammatory Bowel Diseases

At PHARMExcel, our operational teams have extensive experience when it comes to conducting GI studies. We understand the everchanging regulatory landscape and the importance of delivering in a timely and expedited manner.

We have a key focus in Inflammatory Bowel Diseases (Crohn’s Disease and Ulcerative Colitis) and have conducted pivotal studies in new and emerging biosimilar technologies.

Infectious Diseases and Vaccines

Our in-house team have a thorough understanding of the complexities of running ID and vaccine trials, having worked on some rare and complex Phase I studies, in both adult and paediatric populations. We ensure maximised efficiency with study planning, regulatory submissions and enrolment.

We have a key focus on rare, infectious diseases.

Ophthalmology

In an aging population we have seen the number of ophthalmic disorders rising with significant healthcare cost implications. Research into novel treatment options therefore, remains a priority.

Here at PHARMExcel, we have developed long-lasting relationships with investigators around the world, including working with some of the world leading eye centres, providing access to some of the latest imaging technologies, including AI. This allows us to guarantee delivery of high quality, clinical trials in this area.

We have a key focus on Acute Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Uveitis.

Oncology / Haematology

With our flexible and pragmatic approach to clinical research delivery, we have earned a reputation for taking on complex and challenging research studies in the area of Oncology/Haematology. We have the capabilities to identify key opinion leaders and high-performing sites, plan and conduct effective studies, expedite study start-up and recruitment and navigate the global regulatory landscape to expedite approvals.

We have a key focus in myeloma, lymphoma, myelodysplastic syndrome, amyloidosis, and haemophilia.

Probiotics

PHARMExcel has partnered with a world leading probiotics company and have been responsible for assisting with the monitoring and oversight of their UK clinical trial programme. We have, to date, undertaken numerous studies covering multiple specialty areas including hepatology, healthy volunteers/athletes, orthopaedics, spinal injuries, gastroenterology and renal.

Cell & Gene Studies

Our experienced in-house team has broad knowledge in ATMP clinical studies. We have delivered first-in-human/patient clinical trials (academic and commercial) in the UK with a focus on rare disease, oncology, haematology and ophthalmology.

With our extensive UK regulatory knowledge and access to MHRA licenced facilities across the UK, we have earned a reputation for delivering complex and challenging ATMP clinical trials efficiently and safely.

You can find out more about our ATMP Studies here.

Medical Devices

Find out more about our Medical Devices here.

Rare diseases

Find out more about our Rare Diseases here.